Different length peptides bind to HLA-Aw68 similarly at their ends but bulge out in the middle
about
Antagonist HIV-1 Gag peptides induce structural changes in HLA B8The three-dimensional structure of a class I major histocompatibility complex molecule missing the alpha 3 domain of the heavy chainFunctional and biophysical characterization of an HLA-A*6801-restricted HIV-specific T cell receptorA post-translational modification of nuclear proteins, N(G),N(G)-dimethyl-Arg, found in a natural HLA class I peptide ligandAn N-acetylated natural ligand of human histocompatibility leukocyte antigen (HLA)-B39. Classical major histocompatibility complex class I proteins bind peptides with a blocked NH(2) terminus in vivoPeptide binding characteristics of the non-classical class Ib MHC molecule HLA-E assessed by a recombinant random peptide approachPoor binding of a HER-2/neu epitope (GP2) to HLA-A2.1 is due to a lack of interactions with the center of the peptideAlternate interactions define the binding of peptides to the MHC molecule IA(b).Structure of HLA-A*0301 in complex with a peptide of proteolipid protein: insights into the role of HLA-A alleles in susceptibility to multiple sclerosisCross-Allele Cytotoxic T Lymphocyte Responses against 2009 Pandemic H1N1 Influenza A Virus among HLA-A24 and HLA-A3 Supertype-Positive IndividualsStructural insights into the molecular ruler mechanism of the endoplasmic reticulum aminopeptidase ERAP1Crystal structure of an H-2Kb-ovalbumin peptide complex reveals the interplay of primary and secondary anchor positions in the major histocompatibility complex binding grooveCrystal structures of HLA-A*0201 complexed with antigenic peptides with either the amino- or carboxyl-terminal group substituted by a methyl groupStructural evidence of T cell xeno-reactivity in the absence of molecular mimicryComputational modeling of laminin N-terminal domains using sparse distance constraints from disulfide bonds and chemical cross-linkingThe structure of a folding intermediate provides insight into differences in immunoglobulin amyloidogenicityHuman cytotoxic T lymphocytes directed to seasonal influenza A viruses cross-react with the newly emerging H7N9 virusIdentification by mass spectrometry of CD8(+)-T-cell Mycobacterium tuberculosis epitopes within the Rv0341 gene productEnhanced detection of human immunodeficiency virus type 1 (HIV-1) Nef-specific T cells recognizing multiple variants in early HIV-1 infection.Microfluidic chemical cytometry of peptide degradation in single drug-treated acute myeloid leukemia cells.Analysis of peptide length preference of the rat MHC class Ia molecule RT1-A(u), by a modified random peptide library approach.Mass spectral data for 64 eluted peptides and structural modeling define peptide binding preferences for class I alleles in two chicken MHC-B haplotypes associated with opposite responses to Marek's diseasePeptide length preferences for rat and mouse MHC class I molecules using random peptide libraries.HLA class I supertypes: a revised and updated classification.Crystallographic analysis of endogenous peptides associated with HLA-DR1 suggests a common, polyproline II-like conformation for bound peptides.A significant number of human immunodeficiency virus epitope-specific cytotoxic T lymphocytes detected by tetramer binding do not produce gamma interferon.Conservation and diversification of MHC class I and its related molecules in vertebrates.HLA-B57-restricted cytotoxic T-lymphocyte activity in a single infected subject toward two optimal epitopes, one of which is entirely contained within the otherDual non-contiguous peptide occupancy of HLA class I evoke antiviral human CD8 T cell response and form neo-epitopes with self-antigens.The ER aminopeptidase, ERAP1, trims precursors to lengths of MHC class I peptides by a "molecular ruler" mechanism.Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motifPredicting HLA class I non-permissive amino acid residues substitutions.Prediction of peptides binding to MHC class I and II alleles by temporal motif miningThe first step of peptide selection in antigen presentation by MHC class I molecules.T-cell antigens in cancerCytotoxic T lymphocyte responses and CTL epitope escape mutation in HBsAg, anti-HBe positive individuals.Epitope Prediction Assays Combined with Validation Assays Strongly Narrows down Putative Cytotoxic T Lymphocyte EpitopesOptimal lymphocytic choriomeningitis virus sequences restricted by H-2Db major histocompatibility complex class I molecules and presented to cytotoxic T lymphocytesTCL1: a shared tumor-associated antigen for immunotherapy against B-cell lymphomas.The optimization of peptide cargo bound to MHC class I molecules by the peptide-loading complex.
P2860
Q24309337-8E04A177-C6E1-463D-AD9E-33508D99674BQ24563048-25CCE953-191A-435A-80A2-1C30FDDADFF9Q24643913-60794628-5766-43F6-B5EE-590372C6441AQ24672491-5D7B2D73-73F2-424B-9263-00B24E3EE87BQ24676272-D1CEF8B4-A66A-4D8C-B1E9-8CA57D9FEA85Q24800285-1F1F99C2-01AB-4F3D-B58F-AA48C05C5579Q27620636-CC43E70A-E4B1-4D53-8F01-41F4338DC702Q27639260-2FEE1865-4B02-4390-AAC3-4A2A744121D0Q27667717-F7F20A31-8177-4D7D-93B0-D182E6B9C5F7Q27673689-9D05134F-3584-4715-80EE-3C98A50CCD0FQ27677415-70B40C50-25E5-4175-B74A-01E521F50499Q27729958-A154A51E-0A02-43C4-9910-0122891322DFQ27765349-755096D1-CBE7-4ECA-97FE-ABAD63280795Q27766708-A4BFF8DB-5F81-48C3-A3CE-2F6B6CD0855AQ28821078-D41F64E4-7BC2-4EA0-9218-9FF3FDECB4F9Q30157531-F94D2C2F-AED3-4B1A-96D3-54ED9FC1BFFCQ30355817-05B24098-1BFA-4261-821E-A8E53491759DQ30453239-89322CB3-0F00-447A-AC04-555DD5E35D10Q30479692-45FE982D-1576-427A-B822-7D347D9B164FQ30540276-CF1943E5-BBFE-4615-8B29-71DF9876703AQ30828570-0587AA9E-0302-46DB-AE25-5D7C15539373Q31162016-22D1561D-96F5-4B34-8C72-D84A895C0BBAQ32065988-D8322612-F7CA-4E78-913D-A75F73581573Q33315730-F2479A65-BCC4-479E-BCB3-06AA76106E60Q33575103-EEDAD9E1-A5AD-4C1A-8C3D-A8D896AFCD0DQ33603919-68C8E664-4895-40C1-AF01-F04423704BD0Q33630631-2A246DA9-7EE4-4169-8580-BDD319B371CAQ33787144-C550CF2F-392B-4583-8ED4-D8884190B7D2Q33894929-CEB4C08B-774C-4C3C-B258-5F107E0D18AAQ34144506-656864DB-1192-4A40-9728-143D173772E6Q34199652-33746B73-A599-4738-874E-0AB788885670Q34384277-17DEC065-3D99-415B-BC28-FB23918C30C5Q34569401-28E8A963-EAD3-475D-A53E-DBF474E0D169Q35062805-9FEB170F-DE68-4388-9F72-600631014560Q35179337-58D49FEA-225B-429F-9F1C-B587998FF875Q35360487-D91BE9A4-BF4E-4A09-9B74-565D1CB47B41Q35827003-34EE03A0-0C89-4611-B2FE-3957303D3AD3Q35837639-AB768091-A00D-4E7F-845E-87F67763B360Q36194235-17B25541-A43D-4EF7-978A-EF9668CF1103Q36266447-AFDD0AF5-2248-4E2B-A5C7-646ADF609859
P2860
Different length peptides bind to HLA-Aw68 similarly at their ends but bulge out in the middle
description
1992 nî lūn-bûn
@nan
1992 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Different length peptides bind ...... ds but bulge out in the middle
@ast
Different length peptides bind ...... ds but bulge out in the middle
@en
Different length peptides bind ...... ds but bulge out in the middle
@nl
type
label
Different length peptides bind ...... ds but bulge out in the middle
@ast
Different length peptides bind ...... ds but bulge out in the middle
@en
Different length peptides bind ...... ds but bulge out in the middle
@nl
prefLabel
Different length peptides bind ...... ds but bulge out in the middle
@ast
Different length peptides bind ...... ds but bulge out in the middle
@en
Different length peptides bind ...... ds but bulge out in the middle
@nl
P2093
P356
P1433
P1476
Different length peptides bind ...... ds but bulge out in the middle
@en
P2093
P2888
P356
10.1038/360364A0
P407
P577
1992-11-26T00:00:00Z
P6179
1037617338